Reducing tumour hypoxia via oral administration of oxygen nanobubbles

Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an oral...

Full description

Bibliographic Details
Main Authors: Owen, J, McEwan, C, Nesbitt, H, Bovornchutichai, P, Averre, R, Borden, M, McHale, A, Callan, J, Stride, E
Format: Journal article
Language:English
Published: Public Library of Science 2016
_version_ 1797051983486517248
author Owen, J
McEwan, C
Nesbitt, H
Bovornchutichai, P
Averre, R
Borden, M
McHale, A
Callan, J
Stride, E
author_facet Owen, J
McEwan, C
Nesbitt, H
Bovornchutichai, P
Averre, R
Borden, M
McHale, A
Callan, J
Stride, E
author_sort Owen, J
collection OXFORD
description Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxia-inducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p<0.001) was found for the animals receiving the oxygen nanobubbles. This magnitude of reduction has been shown in previous studies to be commensurate with an improvement in outcome with both radiation and drug-based treatments. In addition, there was a significant reduction in the expression of vascular endothelial growth factor (VEGF) in this group and corresponding increase in the expression of arrest-defective protein 1 homolog A (ARD1A).
first_indexed 2024-03-06T18:26:45Z
format Journal article
id oxford-uuid:083d1cb1-b6c7-41a6-a7be-d0fa8b5c08bf
institution University of Oxford
language English
last_indexed 2024-03-06T18:26:45Z
publishDate 2016
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:083d1cb1-b6c7-41a6-a7be-d0fa8b5c08bf2022-03-26T09:11:48ZReducing tumour hypoxia via oral administration of oxygen nanobubblesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:083d1cb1-b6c7-41a6-a7be-d0fa8b5c08bfEnglishSymplectic Elements at OxfordPublic Library of Science2016Owen, JMcEwan, CNesbitt, HBovornchutichai, PAverre, RBorden, MMcHale, ACallan, JStride, EHypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxia-inducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p<0.001) was found for the animals receiving the oxygen nanobubbles. This magnitude of reduction has been shown in previous studies to be commensurate with an improvement in outcome with both radiation and drug-based treatments. In addition, there was a significant reduction in the expression of vascular endothelial growth factor (VEGF) in this group and corresponding increase in the expression of arrest-defective protein 1 homolog A (ARD1A).
spellingShingle Owen, J
McEwan, C
Nesbitt, H
Bovornchutichai, P
Averre, R
Borden, M
McHale, A
Callan, J
Stride, E
Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title_full Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title_fullStr Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title_full_unstemmed Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title_short Reducing tumour hypoxia via oral administration of oxygen nanobubbles
title_sort reducing tumour hypoxia via oral administration of oxygen nanobubbles
work_keys_str_mv AT owenj reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT mcewanc reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT nesbitth reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT bovornchutichaip reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT averrer reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT bordenm reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT mchalea reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT callanj reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles
AT stridee reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles